María
Díez Campelo
University of Groningen
Groninga, HolandaPublicaciones en colaboración con investigadores/as de University of Groningen (4)
2021
-
Daratumumab in transfusion-dependent patients with low or intermediate-1 risk myelodysplastic syndromes
American Journal of Hematology
-
Imetelstat achieves meaningful and durable transfusion independence in high transfusion–Burden patients with lower-risk myelodysplastic syndromes in a phase II study
Journal of Clinical Oncology, Vol. 39, Núm. 1, pp. 48-56
-
Toxic iron species in lower-risk myelodysplastic syndrome patients: course of disease and effects on outcome
Leukemia, Vol. 35, Núm. 6, pp. 1745-1750
2020
-
Luspatercept in patients with lower-risk myelodysplastic syndromes
New England Journal of Medicine, Vol. 382, Núm. 2, pp. 140-151